Stock Notes

Metropolis Healthcare

Every Finvezto stock note on Metropolis Healthcare, dated and newest first. Coverage spans diagnostics / healthcare.

1 note and counting
05 Jul 2026
Metropolis Healthcare's Q1 FY27 business update shows consolidated revenue up about 16 percent year on year, led by patient-test volumes.
A better product mix aided realisation, the TruHealth wellness and specialty test segments were the fastest-growing, and EBITDA margins improved year on year in line with guidance.
Finvezto Membership

Get the research behind the notes

Stock notes are the free daily layer. The membership carries the full Flexi-Wealth system: an ETF core portfolio with monthly rebalancing signals, fifteen quality-momentum stocks with exact weightages every month, options income and hedging recommendations, and the institutional data toolkit. One flat membership covers everything.

Become a Member Read free sample research →

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.